{"provider": "google_genai", "model": "gemini-flash-lite-latest", "text": "{\"grade\": 0, \"reasoning\": \"The criterion specifically asks whether the response suggests that a small number of executives (e.g., 2-5 FTEs) are sufficient substance for a major pharma group's global IP principal. The candidate answer explicitly refuses to recommend a specific structure and instead outlines why such aggressive profit shifting is likely to fail HMRC scrutiny (GAAR, transfer pricing, DPT). It does not propose or suggest any specific staffing level (like 2-5 FTEs) as sufficient substance for an IP principal.\", \"criterion_id\": \"77a6a9a4-85a5-4ef3-a58c-6a3623970e43\"}", "usage": {"prompt_tokens": 799, "completion_tokens": 154, "total_tokens": 953}, "latency_s": 14.741714249947108, "request_id": "yt6UaaP5O-OJxN8Po4aNmAM", "raw_response": null}